Tysabri can treat MS effectively
Recent tests of Tysabri (developed by the Irish company Elan) have come up with positive results which were put before the World Congress on Treatment and Research in Multiple Sclerosis in Montreal. The doctors have concluded that the drug has the potential to come up as an effective treatment for patients suffering with multiple sclerosis. The medication is also useful in slowing down the progression of disability.
- Pramipexole might help reduce sleep disturbance
- UCI to study novel method to treat pain, depression
- Anti-inflammatory medications can treat schizophrenia: Study
- Tamoxifen may ease bipolar mania symptoms
Lauren on 24 Sep 2008 at 3:15 pm #
The best part of this new data released on September 19, 2008 states the following:
“TYSABRI is the Only Marketed MS Treatment to Show Both Significant Slowing in Disability Progression and Sustained Improvement in Physical Disability”…, it is no wonder that some MS patients are reporting improvements in their symptoms. This is why I firmly believe that Tysabri should used as soon as possible as a first-line therapy for MS (giving the patient’s body a better chance to heal itself), and NOT waiting to be used as a second-line or “rescue therapy” because by then, the relapses suffered by the patient may have left possible permanent damage.
I have had 25 infusions of Tysabri so far, and I am so grateful for this medication.